Open Access

[Retracted] Overexpression of indoleamine 2, 3‑dioxygenase contributes to the repair of human airway epithelial cells inhibited by dexamethasone via affecting the MAPK/ERK signaling pathway

  • Authors:
    • Shanshan Jia
    • Pin Guo
    • Xiangjin Ge
    • Huanhuan Wu
    • Junhua Lu
    • Xiaofang Fan
  • View Affiliations

  • Published online on: February 19, 2024     https://doi.org/10.3892/etm.2024.12432
  • Article Number: 144
  • Copyright : © Jia et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Article

Related Articles

Journal Cover

April-2024
Volume 27 Issue 4

Print ISSN: 1792-0981
Online ISSN:1792-1015

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Jia S, Guo P, Ge X, Wu H, Lu J and Fan X: [Retracted] Overexpression of indoleamine 2, 3‑dioxygenase contributes to the repair of human airway epithelial cells inhibited by dexamethasone via affecting the MAPK/ERK signaling pathway. Exp Ther Med 27: 144, 2024
APA
Jia, S., Guo, P., Ge, X., Wu, H., Lu, J., & Fan, X. (2024). [Retracted] Overexpression of indoleamine 2, 3‑dioxygenase contributes to the repair of human airway epithelial cells inhibited by dexamethasone via affecting the MAPK/ERK signaling pathway. Experimental and Therapeutic Medicine, 27, 144. https://doi.org/10.3892/etm.2024.12432
MLA
Jia, S., Guo, P., Ge, X., Wu, H., Lu, J., Fan, X."[Retracted] Overexpression of indoleamine 2, 3‑dioxygenase contributes to the repair of human airway epithelial cells inhibited by dexamethasone via affecting the MAPK/ERK signaling pathway". Experimental and Therapeutic Medicine 27.4 (2024): 144.
Chicago
Jia, S., Guo, P., Ge, X., Wu, H., Lu, J., Fan, X."[Retracted] Overexpression of indoleamine 2, 3‑dioxygenase contributes to the repair of human airway epithelial cells inhibited by dexamethasone via affecting the MAPK/ERK signaling pathway". Experimental and Therapeutic Medicine 27, no. 4 (2024): 144. https://doi.org/10.3892/etm.2024.12432